Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Teresa López Fernández"'
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Anthracycline-based chemotherapy represents a cornerstone treatment for a number of common cancers, including breast cancer, lymphoma, and sarcoma. However, anthracycline-induced cardiotoxicity remains a significant concern, often
Externí odkaz:
https://doaj.org/article/ba5225daee1b4409a7606a7683812975
Autor:
Zorba Blázquez Bermejo, Teresa López Fernández, Ulises Ramírez Valdiris, Juan Caro Codón, Inés Ponz de Antonio, Sandra Rosillo Rodríguez, José María Mesa García, Mar Moreno Yangüela
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 36, Iss 4, Pp 319-320 (2017)
Externí odkaz:
https://doaj.org/article/675287bcc7fc4b9cb419a83da71c79f7
Autor:
Zahra Raisi-Estabragh, Ofer Kobo, Teresa López-Fernández, Husam Abdel Qadir, Nicholas WS. Chew, Wojtek Wojakowski, Abhishek Abhishek, Robert J.H. Miller, Mamas A. Mamas
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 19, Iss , Pp 200218- (2023)
Background: Temporal trends of the impact of social determinants on cardiovascular outcomes of cancer patients has not been previously studied. Objectives: This study examined social disparities in cardiovascular mortality of people with and without
Externí odkaz:
https://doaj.org/article/440f32078c3643bd880ceaba381a111d
Publikováno v:
Archivos Peruanos de Cardiología y Cirugía Cardiovascular, Vol 2, Iss 2, Pp 103-111 (2021)
Las enfermedades cardiovasculares y las enfermedades oncológicas constituyen la primera y segunda causa de muerte a nivel mundial. Los pacientes oncológicos tienen más riesgo de muerte cardiovascular, y los pacientes cardiacos tienen más riesgo d
Externí odkaz:
https://doaj.org/article/e18667e06fe8431f88ca99bcd2ff9d50
Autor:
Francesco Perone, Pilar Zamora Auñon, Laura Rodríguez, David Vinal, Juan Caro-Codon, Ana Pertejo, Virginia Martínez Marín, Enrique Espinosa, Teresa López-Fernández
Publikováno v:
Monaldi Archives for Chest Disease (2022)
Trastuzumab therapy has dramatically changed breast cancer prognosis. Consensus documents recommend a close monitoring during therapy, not always feasible, especially in metastatic breast cancer. The purpose of this study is to describe trastuzumab c
Externí odkaz:
https://doaj.org/article/54e4f67b8480419bb45a6a437a16204d
Autor:
Ana Martín‐Garcia, Teresa López‐Fernández, Cristina Mitroi, Marinela Chaparro‐Muñoz, Pedro Moliner, Agustin C. Martin‐Garcia, Amparo Martinez‐Monzonis, Antonio Castro, Jose L. Lopez‐Sendon, Pedro L. Sanchez
Publikováno v:
ESC Heart Failure, Vol 7, Iss 2, Pp 763-767 (2020)
Abstract Aims Current guidelines recommend sacubitril/valsartan for patients with heart failure and reduced left ventricular ejection fraction (LVEF), but there is lack of evidence of its efficacy and safety in cancer therapy‐related cardiac dysfun
Externí odkaz:
https://doaj.org/article/e8b9384e425e41ca8977b262e11b1e4d
Autor:
Teresa López-Fernández
Publikováno v:
JACC: CardioOncology. 5:186-188
Autor:
Eduardo Zatarain-Nicolás, Pilar Martín, Iván Márquez Rodas, Juan Virizuela, Ana Martín García, Cristina Mitroi, Juan Cosín Sales, Vivencio Barrios, Fátima Sánchez-Cabo, Borja Ibañez, Javier de Castro Carpeño, Teresa López Fernández
Publikováno v:
Clinical and Translational Oncology.
Autor:
Mohamed Dafaalla, Husam Abdel-Qadir, Chris P Gale, Louise Sun, Teresa López-Fernández, Robert J H Miller, Wojtek Wojakowski, James Nolan, Muhammad Rashid, Mamas A Mamas
Publikováno v:
European Heart Journal - Quality of Care and Clinical Outcomes.
AimsTo assess processes of care and clinical outcomes in cancer patients with ST elevation myocardial infarction (STEMI) according to cancer type.Methods and resultsThis is a national population-based study of patients admitted with STEMI in the UK b
Autor:
Joerg Herrmann, Daniel Lenihan, Saro Armenian, Ana Barac, Anne Blaes, Daniela Cardinale, Joseph Carver, Susan Dent, Bonnie Ky, Alexander R Lyon, Teresa López-Fernández, Michael G Fradley, Sarju Ganatra, Giuseppe Curigliano, Joshua D Mitchell, Giorgio Minotti, Ninian N Lang, Jennifer E Liu, Tomas G Neilan, Anju Nohria, Rupal O'Quinn, Iskra Pusic, Charles Porter, Kerry L Reynolds, Kathryn J Ruddy, Paaladinesh Thavendiranathan, Peter Valent
Publikováno v:
Eur Heart J
The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and management of CV complications or toxicities of cancer therapies,